Megagen Implant Files for Inspector to Probe Ray's EGM Legality... Risk of EGM Invalidation and Escalating Management Dispute
On May 22, 2026, shareholder Megagen Implant filed a petition to appoint an inspector to investigate the legality of Ray's extraordinary general meeting (EGM) scheduled for May 28.
The petitioner demands investigation into six areas, including omission of meeting notices, obstruction of voting rights, and improper denial of attendance.
Ray stated it will respond according to legal procedures, but the escalation of management dispute into litigation raises risks of EGM invalidation and decision-making delays.
For shareholders, increased uncertainty and legal costs weigh on short-term stock price. (Downside risk for stock outlook)
[AI Comprehensive Analysis]This petition raises serious questions about management's handling of the EGM; if procedural violations are confirmed, the EGM resolutions could be voided. Ray's response is critical to restoring shareholder trust, and prolonged litigation may damage enterprise value.
KOSDAQ Filing Information
Filing: Filing of Lawsuit, etc. (Management Dispute Lawsuit) (Appointment of Inspector)